Ultrasonic Electrosurgical Devices Market Report Scope & Overview:

The Ultrasonic Electrosurgical Devices Market was valued at USD 3.99 Billion in 2025 and is expected to reach USD 8.56 Billion by 2035, growing at a CAGR of 7.93% from 2026 to 2035.

The ultrasonic electrosurgery platform is a high-end surgical energy platform that combines use of electrosurgical technology along with ultrasonic technology in one single surgical tool making use of vibrations of high frequency which are converted to mechanical energy to perform surgical cuts. The devices allow precision cutting and coagulation of tissues along with vessel sealing without causing any significant damage to nearby tissues, providing a precision-based alternative to traditional surgery which has proved especially useful for minimally invasive surgery. The demand for these devices is expected to rise due to adoption of multi-energy platforms by hospitals, margin improvement from high value outpatient cases at ambulatory centers, opioids saving devices encouraged by payers and also due to increasing robotic surgery.

Johnson & Johnson, through its Ethicon subsidiary, stands out as the leading company in the ultrasonic electrosurgical devices market, driven by its pioneering HARMONIC ultrasonic energy devices and robust global footprint spanning North America, Europe, Asia-Pacific, and beyond, with reliable performance in minimally invasive surgeries where precision cutting and coagulation minimize thermal damage to tissues.

To Get more information Ultrasonic Electrosurgical Devices Market - Request Free Sample Report

Ultrasonic Electrosurgical Devices Market Trends

• Regional reimbursement changes, including United States CY2025 separate payments for non-opioid devices, directly accelerate capital purchases.
• Robot-assisted surgery continues expanding procedure throughput and pushing device makers toward articulated ultrasonic tips fitting robotic wrists.
• Next-generation ultrasonic devices continue offering improved feedback mechanisms and enhanced safety protocols to increase surgical precision.
• Hospitals continue upgrading to multi-energy platforms while ambulatory centers pursue higher-margin outpatient surgical cases.
• Innovations in high-intensity focused ultrasound and magnetic resonance-guided focused ultrasound continue transforming treatment landscapes.

The United States Ultrasonic Electrosurgical Devices Market Outlook

The United States Ultrasonic Electrosurgical Devices Market was valued at USD 1.26 Billion in 2025 and is expected to reach USD 2.72 Billion by 2035, growing at a CAGR of 8.00% from 2026 to 2035.

The United States market continues to benefit from regional reimbursement changes, including CY2025 separate payments for non-opioid devices, that directly accelerate capital purchases of ultrasonic electrosurgical equipment. Increasing surgical procedure volumes, rising prevalence of chronic diseases requiring surgical intervention, and significant advancements in surgical techniques continued reinforcing demand across the country's largest hospital systems and ambulatory surgical center networks throughout the year.

Olympus continued commanding a significant market share position in 2025, together with Medtronic capturing a substantial portion of American ultrasonic electrosurgical device demand amid global production reaching approximately 6.27 million units across the industry.

Ultrasonic Electrosurgical Devices Market Segmentation Analysis

• By Product Type, the consumables segment held approximately 54.20% share in the ultrasonic electrosurgical devices market in 2025, while the generators segment is the fastest growing.
• By Application, the general surgery segment held approximately 32.80% share in the ultrasonic electrosurgical devices market in 2025, while the cardiology segment is the fastest growing.
• By Type, the high-intensity focused ultrasonic ablators segment held approximately 40.00% share in the ultrasonic electrosurgical devices market in 2025, while the magnetic resonance-guided focused ultrasonic ablators segment is the fastest growing.
• By End-User, the hospital segment held approximately 48.50% share in the ultrasonic electrosurgical devices market in 2025, while the ambulatory surgical centers segment is the fastest growing.

By Product Type, consumables segment dominates the ultrasonic electrosurgical devices market, while generators grows fastest

The consumables segment held approximately 54.20% of total market revenue in 2025, reflecting the recurring nature of consumable purchases, including ultrasonic scalpels and disposable tips, that continue generating steady, predictable revenue across every surgical procedure. That recurring revenue characteristic continues to keep consumables firmly at the top of the broader product type segmentation across nearly every major ultrasonic electrosurgical device deployment worldwide.

The generators segment is projected to grow at the fastest CAGR during the forecast period, as hospitals continue upgrading to multi-energy platforms that integrate ultrasonic and advanced bipolar capability into unified generator systems. Continued hospital capital equipment investment in next-generation generator platforms continues to push this product type category's growth rate ahead of the broader product type segmentation.

By Application, general surgery segment dominates the ultrasonic electrosurgical devices market, while cardiology grows fastest

The general surgery segment held approximately 32.80% of total market revenue in 2025, anchored by the broad range of laparoscopic and open surgical procedures across abdominal, bariatric, and gynecological applications that continue relying on ultrasonic energy for precise tissue dissection. That broad procedural applicability continues to keep general surgery firmly at the top of the broader application segmentation across nearly every major surgical specialty worldwide.

The cardiology segment is projected to grow at the fastest CAGR during the forecast period, as cardiac procedures increasingly incorporate ultrasonic energy-based tools for precise tissue ablation and vessel sealing in minimally invasive cardiac interventions. Rising adoption of ultrasonic technology in cardiac surgical applications continues to push this application segment's growth rate ahead of the broader application segmentation.

By Type, high-intensity focused ultrasonic ablators segment dominates the ultrasonic electrosurgical devices market, while magnetic resonance-guided focused ultrasonic ablators grows fastest

The high-intensity focused ultrasonic ablators segment held approximately 40.00% of total market revenue in 2025, favored for its established, non-invasive tissue ablation capability that continues finding application across a broad range of surgical and therapeutic procedures. That established therapeutic versatility continues to keep this segment firmly at the top of the broader type segmentation across the majority of ultrasonic electrosurgical device deployments worldwide.

The magnetic resonance-guided focused ultrasonic ablators segment is projected to grow at the fastest CAGR during the forecast period, as innovations in this combined imaging-and-treatment technology continue transforming treatment landscapes for applications requiring real-time visualization during ablation procedures. Continued technological advancement in image-guided ablation continues to push this type category's growth rate ahead of the broader type segmentation.

By End-User, hospital segment dominates the ultrasonic electrosurgical devices market, while ambulatory surgical centers grows fastest

The hospital segment held approximately 48.50% of total market revenue in 2025, anchored by comprehensive surgical infrastructure and specialist availability required for complex procedures utilizing ultrasonic electrosurgical technology. That established surgical infrastructure continues to keep hospitals firmly at the top of the broader end-user segmentation across nearly every major ultrasonic electrosurgical device application worldwide.

The ambulatory surgical centers segment is projected to grow at the fastest CAGR during the forecast period, as these centers continue pursuing higher-margin outpatient surgical cases that ultrasonic electrosurgical technology's precision and reduced thermal damage characteristics make increasingly suitable for outpatient settings. Rising shift of appropriate surgical procedures toward ambulatory settings continues to push this end-user category's growth rate ahead of the broader end-user segmentation.

Regional Analysis

North America Ultrasonic Electrosurgical Devices Market Insights

North America held the largest share of the global ultrasonic electrosurgical devices market in 2025, at approximately 37.00%, supported by regional reimbursement changes that directly accelerate capital purchases of ultrasonic electrosurgical equipment. Hospitals upgrading to multi-energy platforms and ambulatory centers pursuing higher-margin outpatient cases continued reinforcing this leadership position throughout the year.

The United States accounted for roughly 84.90% of regional revenue, reflecting its concentration of leading medical device manufacturers and comprehensive hospital and ambulatory surgical center infrastructure. Canada contributed a smaller but steadily growing share of regional revenue, supported by its own expanding surgical technology adoption, keeping North America firmly ahead of every other region in this market.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Ultrasonic Electrosurgical Devices Market Insights

Europe held a substantial share of the global ultrasonic electrosurgical devices market in 2025, supported by strong surgical technology manufacturing capability and comprehensive national health insurance coverage across the continent. Germany accounted for roughly 27.20% of regional revenue, supported by its concentration of medical device manufacturers and advanced hospital surgical infrastructure.

France, the United Kingdom, and Italy followed a broadly similar trajectory, as continued investment in minimally invasive surgical technology extended ultrasonic electrosurgical device demand across the continent's largest healthcare markets. Continued emphasis on reducing surgical complication rates is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Ultrasonic Electrosurgical Devices Market Insights

Asia Pacific was the fastest-growing region in the global ultrasonic electrosurgical devices market, driven by expanding healthcare infrastructure investment, rising surgical procedure volumes, and growing adoption of minimally invasive surgical techniques across the region's largest and most populous economies. Rapid hospital infrastructure expansion continued driving regional demand at a pace considerably faster than more mature Western markets.

China accounted for roughly 36.40% of regional revenue, supported by expanding domestic hospital infrastructure and growing surgical technology manufacturing capability. Japan and South Korea contributed significant additional regional demand through their own advanced surgical technology adoption, reinforcing Asia Pacific's position as the clear growth leader in this market.

MEA & Latin America Ultrasonic Electrosurgical Devices Market Insights

The region comprising the Middle East and Africa saw continued increase in the use of ultrasonic electrosurgery devices in 2025 as a result of increased spending on hospital infrastructure development and increasing government backing for the latest technological advancements in surgery. UAE represented about 26.30% of revenues in the region, fueled by modernization initiatives in health care and minimally invasive surgeries.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.10% of regional revenue, where growing surgical infrastructure investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional hospital surgical capacity expanded further through the remainder of the forecast period.

Growth Drivers: Reimbursement Reform and Robot-Assisted Surgery Expansion

Regional reimbursement changes, such as United States CY2025 separate payments for non-opioid devices, directly accelerate capital purchases as payers reward opioid-sparing technologies. Demand continues growing as hospitals upgrade to multi-energy platforms and ambulatory centers chase higher-margin outpatient cases, reinforcing structural demand growth across nearly every major surgical setting worldwide.

Robot-assisted surgery continues expanding procedure throughput and pushing device makers to engineer articulated ultrasonic tips that fit robotic wrists, opening new integration pathways for ultrasonic energy platforms. Increasing demand for minimally invasive surgery, combined with technological advancements in transducer design and energy delivery systems, continues reinforcing sustained market expansion through the forecast period.

Restraints: High Entry Barriers and Regulatory Classification Requirements

As a result of the high barrier to entry and other stringent class three medical device laws in the industry, large companies with sufficient resources dominate the market while leaving the new entrants behind. This is due to the fact that the two major competitors in this industry have over ninety percent of the total market share.

The semi-consolidated competitive landscape, characterized by high entry barriers, continues limiting the pace at which mid-sized innovators and emerging regional players can meaningfully challenge established market leaders. That competitive concentration continues shaping pricing dynamics and innovation pathways across the broader ultrasonic electrosurgical devices market.

Opportunities: Robotic Platform Integration and Image-Guided Ablation Advancement

Continued engineering of articulated ultrasonic tips designed to fit robotic surgical platform wrists presents substantial opportunity for manufacturers positioned to serve the expanding robot-assisted surgery segment. Manufacturers capable of delivering genuinely compatible, robotically-integrated ultrasonic technology stand to capture a growing share of demand as robotic surgery adoption continues expanding.

Continued innovation in magnetic resonance-guided focused ultrasound technology presents a further significant growth avenue, as this combined imaging-and-treatment approach continues transforming treatment landscapes for procedures requiring real-time visualization. Manufacturers capable of delivering genuinely integrated image-guided ablation systems stand to capture meaningful new revenue streams through 2035.

Recent Developments:

• 2025: Stryker continued expanding its surgical energy device portfolio, strengthening its position serving hospitals and ambulatory surgical centers requiring precise, minimally invasive tissue dissection technology.
• 2025: Medtronic continued advancing its energy-based surgical device technology, targeting hospital systems seeking integrated multi-energy platforms combining ultrasonic and advanced bipolar capability.
• 2025: CONMED continued developing its surgical energy device pipeline, focusing on solutions designed to support minimally invasive procedures across general surgery and specialty surgical applications.

Ultrasonic Electrosurgical Devices Market key players are:

• Ethicon, Inc.
• Olympus Corporation
• Surgnova Healthcare Technologies
• Medtronic plc
• B. Braun Melsungen AG
• Apyx Medical Corporation
• CONMED Corporation
• Erbe Elektromedizin GmbH
• Stryker Corporation
• Smith & Nephew plc
• Boston Scientific Corporation
• KLS Martin Group
• Bowa-electronic GmbH & Co. KG
• Genesis MedTech
• Misonix, Inc.
• Integra LifeSciences Corporation
• Karl Storz SE & Co. KG
• Richard Wolf GmbH
• Zimmer Biomet Holdings, Inc.
• Reach Surgical, Inc.

Ultrasonic Electrosurgical Devices Market Report Scope :